Ibio Inc

Change company Symbol lookup

Select an option...

IBIO Ibio Inc

ADAG Adagene Inc

TSLA Tesla Inc

APCX AppTech Payments Corp

CURV Torrid Holdings Inc

MMSBF Megmilk Snow Brand Co Ltd

ETV Eaton Vance Tax-Managed Buy-Write Opportunities Fund

CEFC Commercial National Financial Corp (Michigan)

CNVCF Bioharvest Sciences Inc

GECC Great Elm Capital Corp

Go

iBio, Inc. is a developer of next-generation biopharmaceuticals using its proprietary artificial intelligence (AI)-Driven Discovery Platform and FastPharming Manufacturing System. The Company is focusing its technologies on the research and development of novel products at its Drug Discovery Center in California. The Company through its FastPharming Manufacturing System and GlycaneeringSM Technologies develop its portfolio of proprietary biologic drug candidates. The Company operates through two segments: Biopharmaceuticals, and Bioprocessing. Its Biopharmaceuticals segment is engaged in large molecule discovery, development, and licensing activities. Its Bioprocessing segment is engaged in contract development and manufacturing services for recombinant proteins. Its pipeline includes IBIO-100, IBIO-101, IBIO-202, and IBIO-400. Its subsidiary, iBio CDMO LLC, provides FastPharming Contract Development and Manufacturing Services along with GlycaneeringSM Development Services.